QualityStocksNewsBreaks – Trxade Group Inc.’s (NASDAQ: MEDS) Corporate Presentation Highlights Milestones, Growing Popularity of Platform
Trxade Group (NASDAQ: MEDS) recently released a corporate presentation that highlights the company’s major milestones, increased revenues and earnings, and the growing popularity of its pharmaceutical platform (http://ibn.fm/4F16k). An article that discusses the presentation, as well as the company’s achievements as they stand today and since its inception, reads, “Founded in 2010 by MEDS CEO Suren Ajjarapu along with MEDS COO and President Prashant Patel, the Trxade Group spent its first three years working on the technology that would underlie its innovative pharmaceutical platform. Dedicated and passionate, Ajjarapu and Patel bootstrapped early development with some $5.5M of their own funds.…